460 related articles for article (PubMed ID: 29093404)
1. Nationwide Survey of 741 Patients with Systemic Amyloid Light-chain Amyloidosis in Japan.
Shimazaki C; Hata H; Iida S; Ueda M; Katoh N; Sekijima Y; Ikeda S; Yazaki M; Fukushima W; Ando Y
Intern Med; 2018 Jan; 57(2):181-187. PubMed ID: 29093404
[TBL] [Abstract][Full Text] [Related]
2. [Current diagnosis and treatment of AL amyloidosis in Japan: a nationwide epidemiological survey].
Shimazaki C
Rinsho Ketsueki; 2019; 60(8):973-978. PubMed ID: 31484898
[TBL] [Abstract][Full Text] [Related]
3. Localized Lymph Node Light Chain Amyloidosis.
Yamamoto A; Fujii N; Obika M; Yamashita T; Otsuka F
Intern Med; 2020 Oct; 59(19):2415-2418. PubMed ID: 32611959
[TBL] [Abstract][Full Text] [Related]
4. Systemic Amyloidosis Recognition, Prognosis, and Therapy: A Systematic Review.
Gertz MA; Dispenzieri A
JAMA; 2020 Jul; 324(1):79-89. PubMed ID: 32633805
[TBL] [Abstract][Full Text] [Related]
5. First Nationwide Survey of 199 Patients with Amyloid A Amyloidosis in Japan.
Okuda Y; Yamada T; Ueda M; Ando Y
Intern Med; 2018 Dec; 57(23):3351-3355. PubMed ID: 30101921
[TBL] [Abstract][Full Text] [Related]
6. Treatment With Bortezomib-based Therapy, Followed by Autologous Stem Cell Transplantation, Improves Outcomes in Light Chain Amyloidosis: A Retrospective Study.
Jain T; Kosiorek HE; Kung ST; Shah VS; Dueck AC; Gonzalez-Calle V; Luft S; Reeder CB; Adams R; Noel P; Larsen JT; Mikhael J; Bergsagel L; Stewart AK; Fonseca R
Clin Lymphoma Myeloma Leuk; 2018 Jul; 18(7):486-492.e1. PubMed ID: 29753692
[TBL] [Abstract][Full Text] [Related]
7. Immunoglobulin light chain amyloidosis: 2018 Update on diagnosis, prognosis, and treatment.
Gertz MA
Am J Hematol; 2018 Sep; 93(9):1169-1180. PubMed ID: 30040145
[TBL] [Abstract][Full Text] [Related]
8. Outcomes from Autologous Hematopoietic Cell Transplantation versus Chemotherapy Alone for the Management of Light Chain Amyloidosis.
Oke O; Sethi T; Goodman S; Phillips S; Decker I; Rubinstein S; Concepcion B; Horst S; Jagasia M; Kassim A; Harrell SL; Langone A; Lenihan D; Rawling KT; Slosky D; Cornell RF
Biol Blood Marrow Transplant; 2017 Sep; 23(9):1473-1477. PubMed ID: 28546074
[TBL] [Abstract][Full Text] [Related]
9. The value of screening biopsies in light-chain (AL) and transthyretin (ATTR) amyloidosis.
Cohen OC; Sharpley F; Gilbertson JA; Wechalekar AD; Sachchithanantham S; Mahmood S; Whelan CJ; Martinez-Naharro A; Fontana M; Lachmann HJ; Hawkins PN; Gillmore JD
Eur J Haematol; 2020 Sep; 105(3):352-356. PubMed ID: 32495369
[TBL] [Abstract][Full Text] [Related]
10. Clinical manifestations at diagnosis in Japanese patients with systemic AL amyloidosis: a retrospective study of 202 cases with a special attention to uncommon symptoms.
Matsuda M; Katoh N; Ikeda S
Intern Med; 2014; 53(5):403-12. PubMed ID: 24583427
[TBL] [Abstract][Full Text] [Related]
11. A retrospective analysis of clinical features and treatment outcome in 21 patients with immunoglobulin M-related light-chain amyloidosis in Japan: a study from the Amyloidosis Research Committee.
Fuchida SI; Ogura M; Ishida T; Hata H; Handa H; Katoh N; Nakaseko C; Sunami K; Katayama Y; Nobata H; Oshiro K; Iida S; Sekijima Y; Naiki H; Shimazaki C
Int J Hematol; 2023 Oct; 118(4):443-449. PubMed ID: 37515656
[TBL] [Abstract][Full Text] [Related]
12. Clinical features and outcomes of systemic amyloidosis with gastrointestinal involvement: a single-center experience.
Lim AY; Lee JH; Jung KS; Gwag HB; Kim DH; Kim SJ; Lee GY; Kim JS; Kim HJ; Lee SY; Lee JE; Jeon ES; Kim K
Korean J Intern Med; 2015 Jul; 30(4):496-505. PubMed ID: 26161016
[TBL] [Abstract][Full Text] [Related]
13. Outcomes of autologous stem cell transplant for cardiac AL-amyloidosis and cardiac light chain deposition disease.
Abdallah AA; Alapat D; Kaur V; Atrash S
J Oncol Pharm Pract; 2020 Jul; 26(5):1128-1133. PubMed ID: 31795821
[TBL] [Abstract][Full Text] [Related]
14. Recurrent diffuse gastric bleeding as a leading symptom of gastrointestinal AL amyloidosis.
Franck C; Venerito M; Weigt J; Roessner A; Malfertheiner P
Z Gastroenterol; 2017 Dec; 55(12):1318-1322. PubMed ID: 29212103
[TBL] [Abstract][Full Text] [Related]
15. Management of AL amyloidosis in 2020.
Palladini G; Milani P; Merlini G
Blood; 2020 Dec; 136(23):2620-2627. PubMed ID: 33270858
[TBL] [Abstract][Full Text] [Related]
16. Local vs. systemic pulmonary amyloidosis-impact on diagnostics and clinical management.
Baumgart JV; Stuhlmann-Laeisz C; Hegenbart U; Nattenmüller J; Schönland S; Krüger S; Behrens HM; Röcken C
Virchows Arch; 2018 Nov; 473(5):627-637. PubMed ID: 30136180
[TBL] [Abstract][Full Text] [Related]
17. Outcome of Cardiac Light-Chain Amyloidosis in the Era of Novel Therapy - A Single-Center Cohort Study of 227 Patients.
Feng J; Zhang C; Shen K; Sun J; Fang Q; Zhang L; Cao X; Zhou D; Li J; Tian Z
Circ J; 2019 Mar; 83(4):775-782. PubMed ID: 30773521
[TBL] [Abstract][Full Text] [Related]
18. Management of the elderly patient with AL amyloidosis.
Nuvolone M; Milani P; Palladini G; Merlini G
Eur J Intern Med; 2018 Dec; 58():48-56. PubMed ID: 29801808
[TBL] [Abstract][Full Text] [Related]
19. Clinical characterization and outcomes of a cohort of colombian patients with AL Amyloidosis.
Lacouture Fierro JA; Ribero Vargas DA; Sánchez Cano J; Gaviria Jaramillo LM; Perilla Suarez OG; Galvez Cárdenas KM; Ospina Ospina S
Colomb Med (Cali); 2023; 54(3):e2025667. PubMed ID: 38107838
[TBL] [Abstract][Full Text] [Related]
20. Bortezomib-based induction followed by stem cell transplantation in light chain amyloidosis: results of the multicenter HOVON 104 trial.
Minnema MC; Nasserinejad K; Hazenberg B; Hegenbart U; Vlummens P; Ypma PF; Kröger N; Wu KL; Kersten MJ; Schaafsma MR; Croockewit S; de Waal E; Zweegman S; Tick L; Broijl A; Koene H; Bos G; Sonneveld P; Schönland S
Haematologica; 2019 Nov; 104(11):2274-2282. PubMed ID: 30923094
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
